Sangamo Therapeutics Inc (LTS:0R1D)
$ 2.18 -0.06 (-2.68%) Market Cap: 492.41 Mil Enterprise Value: 480.93 Mil PE Ratio: 0 PB Ratio: 12.55 GF Score: 41/100

Sangamo Therapeutics Inc R&D Day Transcript

Dec 17, 2019 / 01:00PM GMT
Release Date Price: $10.69
McDavid Stilwell
Sangamo Therapeutics, Inc. - SVP of Corporate Communications & IR

Good morning. Thank you for braving the nasty weather today. We're excited to have you all here for Sangamo's R&D Day Event. An R&D day is the type of event that forward-looking statements were made for. So I'd like to remind everyone that the projections and forward-looking statements that we discuss during today's event and webcast are based upon the information that we have available today. Please refer to the discussion of the risks, uncertainties and assumptions that are detailed in the forward-looking statements in this presentation as well as in the documents that we file with the Securities and Exchange Commission.

And we have a full agenda. We're going to run through our clinical and preclinical pipeline and detail certain capabilities and technologies. And so with that, I will hand the podium over to Sandy.

Alexander D. Macrae
Sangamo Therapeutics, Inc. - CEO, President & Director

Good morning. Thank you for coming and thank you to New York

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot